Résumé:
Introduction: After mild COVID-19 that does not require hospitalization, some
individuals develop persistent symptoms that may worsen over time, producing a
multisystemic condition termed Post-COVID condition (PCC). Among other
disorders, PCC is characterized by persistent changes in the immune system
that may not be solved several months after COVID-19 diagnosis.
Methods: People with PCC were recruited to determine the distribution and
functionality of CD4+ T helper (Th) subsets in comparison with individuals with
mild, severe, and critical presentations of acute COVID-19 to evaluate their
contribution as risk or protective factors for PCC.
Results: People with PCC showed low levels of Th1 cells, similar to individuals
with severe and critical COVID-19, although these cells presented a higher
capacity to express IFNg in response to stimulation. Th2/Th1 correlation was
negative in individuals with acute forms of COVID-19, but there was no
significant Th2/Th1 correlation in people with PCC. Th2 cells from people with
PCC presented high capacity to express IL-4 and IL-13, which are related to low
ventilation and death associated with COVID-19. Levels of proinflammatory Th9
and Th17 subsets were significantly higher in people with PCC in comparison
with acute COVID-19, being Th1/Th9 correlation negative in these individuals,
which probably contributed to a more pro-inflammatory than antiviral scenario.
Th17 cells from approximately 50% of individuals with PCC had no capacity to
express IL-17A and IL-22, similar to individuals with critical COVID-19, which
would prevent clearing extracellular pathogens. Th2/Th17 correlation waspositive in people with PCC, which in the absence of negative Th1/Th2
correlation could also contribute to the proinflammatory state. Finally, Th22
cells from most individuals with PCC had no capacity to express IL-13 or IL-22,
which could increase tendency to reinfections due to impaired
epithelial regeneration.
Discussion: People with PCC showed skewed polarization of CD4+ Th subsets
with altered functionality that was more similar to individuals with severe and
critical presentations of acute COVID-19 than to people who fully recovered
from mild disease. New strategies aimed at reprogramming the immune
response and redirecting CD4+ Th cell polarization may be necessary to
reduce the proinflammatory environment characteristic of PCC.